EUVIMEDEUVIMED entdecken
Crossref

Hospital-Based Prevalence and Factors Associated with Rifampicin-Resistant Tuberculosis Among Patients with Xpert MTB/RIF-Confirmed Tuberculosis at a Tertiary Referral Hospital in Benue State, North-Central Nigeria

Adah Emmanuel Otache, Omoregie Irowa, Emmanuel Amaechi Nwobi, Ntat Charles Ibiok, Damion Oche, Dam Enye Agada, A. J. Onyewuchi, Audu Onyemocho, Stephen Obekpa Abah

Tropical Journal of Medicine and Basic Sciences · 09.09.2026

DOI: 10.1234/2kw5js25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Journal of Medicine and Basic Sciences, erschienen am 09.09.2026. Verfasst von Adah Emmanuel Otache und 8 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Rifampicin-resistant tuberculosis (RR-TB) remains a major challenge to tuberculosis control. Evidence from tertiary referral institutions in North-Central Nigeria is limited, and facility-based estimates require careful interpretation because referral centres concentrate complex cases. This study determined the hospital-based prevalence of RR-TB and factors associated with rifampicin resistance among patients with Xpert MTB/RIF-confirmed tuberculosis at the Federal University of Health Sciences Teaching Hospital, Otukpo, Benue State.

Methods

We conducted a retrospective hospital-based cross-sectional review of records of adults aged ≥18 years with Xpert-confirmed tuberculosis managed from February 1, 2023, to January 31, 2026. Total population sampling was used. Categorical associations were assessed using chi-square or Fisher’s exact tests, followed by multivariable logistic regression. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were reported.

Results

Of 410 eligible patients, 110 had RR-TB and 300 had rifampicin-susceptible TB, giving a hospital-based RR-TB prevalence of 26.8% (95% CI: 22.6%–31.3%). HIV-positive status (aOR 4.88; 95% CI: 2.93–8.13), male sex (aOR 1.82; 95% CI: 1.17–2.83), and current smoking (aOR 1.72; 95% CI: 1.10–2.69) were independently associated with RR-TB. Diabetes mellitus showed an inverse association (aOR 0.09; 95% CI: 0.03–0.30), but only three RR-TB patients had documented diabetes, warranting cautious interpretation.

Conclusion

More than one-quarter of Xpert-confirmed TB patients at this tertiary referral centre had RR-TB. Integrated TB/HIV care, smoking cessation, and rapid molecular diagnosis should be strengthened. These findings should not be extrapolated as population prevalence estimates.

Schlagwörter

rifampicin-resistant tuberculosisrifampicin resistanceXpert MTB/RIFtuberculosis prevalencerisk factorsHIV coinfectionsmokingdiabetes mellitustertiary care hospitalBenue State

Zitieren

APA

Otache, A. E., Irowa, O., Nwobi, E. A., Ibiok, N. C., Oche, D., Agada, D. E., Onyewuchi, A. J., Onyemocho, A., & Abah, S. O. (2026). Hospital-Based Prevalence and Factors Associated with Rifampicin-Resistant Tuberculosis Among Patients with Xpert MTB/RIF-Confirmed Tuberculosis at a Tertiary Referral Hospital in Benue State, North-Central Nigeria. Tropical Journal of Medicine and Basic Sciences. https://doi.org/10.1234/2kw5js25

Vancouver

Otache AE, Irowa O, Nwobi EA, Ibiok NC, Oche D, Agada DE, et al. Hospital-Based Prevalence and Factors Associated with Rifampicin-Resistant Tuberculosis Among Patients with Xpert MTB/RIF-Confirmed Tuberculosis at a Tertiary Referral Hospital in Benue State, North-Central Nigeria. Tropical Journal of Medicine and Basic Sciences. 2026. doi:10.1234/2kw5js25

BibTeX
@article{Otache2026,
  author = {Otache, Adah Emmanuel and Irowa, Omoregie and Nwobi, Emmanuel Amaechi and Ibiok, Ntat Charles and Oche, Damion and Agada, Dam Enye and Onyewuchi, A. J. and Onyemocho, Audu and Abah, Stephen Obekpa},
  title = {Hospital-Based Prevalence and Factors Associated with Rifampicin-Resistant Tuberculosis Among Patients with Xpert MTB/RIF-Confirmed Tuberculosis at a Tertiary Referral Hospital in Benue State, North-Central Nigeria},
  journal = {Tropical Journal of Medicine and Basic Sciences},
  year = {2026},
  doi = {10.1234/2kw5js25}
}
Kostenlos starten →